President Obama’s FY 2014 budget proposal would make FDA increasingly reliant on user fees, which are slated to make up close to two-thirds of the agency’s $1.3 billion in human drugs program spending, up from just over 50% of spending in FY 2012 – a shift driven by both the growth of user fee programs and cuts to taxpayer funding.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?